Oisin Biotechnologies Patents – Insights & Stats (Updated 2023)

Oisin Biotechnologies has a total of 40 patents globally, out of which 6 have been granted. Of these 40 patents, more than 62% patents are active. The USA is where Oisin Biotechnologies has filed the maximum number of patents, followed by Australia and Europe (EPO). Parallelly, the USA seems to be the main focused R&D center of Oisin Biotechnologies and is also the origin country of the firm.

Oisin Biotechnologies was founded in the year 2014 by Garry Hudson, Kevin Perrott and Matthew Scholz. The company is a drug development firm focused on mitigating the senolytic technology to combat age-related diseases.

Do read about some of the most popular patents of Oisin Biotechnologies which have been covered by us in this article and also you can find Oisin Biotechnologies patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Oisin Biotechnologies patent portfolio.

How many patents does Oisin Biotechnologies have?

Oisin Biotechnologies has a total of 40 patents globally. These patents belong to 5 unique patent families. Out of 40 patents, 25 patents are active.

How Many Patents did Oisin Biotechnologies File Every Year?

Oisin Biotechnologies Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantOisin Biotechnologies Applications FiledOisin Biotechnologies Patents Granted
202231
202123
20203
20198
20188
2017
20161
20154
201411

How many Oisin Biotechnologies patents are Alive/Dead?

Worldwide Patents

Oisin Biotechnologies Patent Portfolio

How Many Patents did Oisin Biotechnologies File in Different Countries?

Oisin Biotechnologies Worldwide Patent Filing

Countries in which Oisin Biotechnologies Filed Patents

CountryPatents
United States Of America8
Australia4
Europe4
China3
Canada3
Korea (South)3
India3
Japan2
Mexico2
Brazil1
Hong Kong (S.A.R.)1
New Zealand1

Where are Research Centres of Oisin Biotechnologies Patents Located?

The R&D Centre of Oisin Biotechnologies is in the United States.

10 Best Oisin Biotechnologies Patents

US20200009268A1 is the most popular patent in the Oisin Biotechnologies portfolio. It has received 10 citations so far from companies like Seed Health.

Below is the list of 10 most cited patents of Oisin Biotechnologies:

Publication NumberCitation Count
US20200009268A110
WO2018129563A19
US20160010110A18
CN105518149A3
CN110678208A2
WO2020163408A32
WO2019204666A12
US11525146B21
CN112312918A1
US20160051700A11

List of Oisin Biotechnologies Patents

Oisin Biotechnologies PatentsTitle
US11603543B2Fusogenic Lipid Nanoparticles For Target Cell-Specific Production Of A Therapeutic Protein
US11525146B2Expression Constructs, Fusogenic Lipid-Based Nanoparticles And Methods Of Use Thereof
US20230348937A1Fusogenic Lipid Nanoparticles For Target Cell-Specific Production Of A Therapeutic Protein Fusogenic Lipid Nanoparticles And Methods Of Manufacture And Use Thereof For The Target Cell-Specific Production Of A Therapeutic Protein And For The Treatment Of A Disease
US20230220422A1Fusogenic Lipid Nanoparticles And Methods For The Manufacture And Use Thereof For The Target Cell-Specific Production Of A Therapeutic Protein And For The Treatment Of A Disease, Condition, Or Disorder Associated With A Target Cell
US20220106608A1Fusogenic Lipid Nanoparticles For The Target Cell-Specific Production Of Rapamycin Inducible Therapeutic Proteins
US20200009268A1Expression Constructs And Systems For Systemic And Non-Specific In Vivo Delivery Of A Nucleic Acid To Human Cells And Transient Target Cell-Specific Production Of A Therapeutic Protein
EP3920888A4Fusogenic Lipid Nanoparticles For The Target Cell-Specific Production Of Rapamycin Inducible Therapeutic Proteins
EP3784252A4Fusogenic Lipid Nanoparticles And Methods For The Manufacture And Use Thereof For The Target Cell-Specific Production Of A Therapeutic Protein And For The Treatment Of A Disease, Condition, Or Disorder Associated With A Target Cell
EP3565607A4Fusogenic Lipid Nanoparticles And Methods For Manufacturing And Use For Therapeutic Protein Production And For Treatment
EP2978854A4Systems And Methods For The Targeted Production Of A Therapeutic Protein Within A Target Cell
CN112312918AFusogenic Lipid Nanoparticles And Methods For The Manufacture And Use Thereof For The Target Cell-Specific Production Of A Therapeutic Protein And For The Treatment Of A Disease, Condition, Or Disorder Associated With A Target Cell
CN110678208AFusogenic Lipid Nanoparticles And Methods For Manufacturing And Use For Therapeutic Protein Production And For Treatment
WO2023056070A3Compositions And Methods For Liver-Specific Expression Of Follistatin
AU2018220160B2Systems And Methods For The Targeted Production Of A Therapeutic Protein Within A Target Cell
AU2018206485A1Fusogenic Lipid Nanoparticles And Methods For Manufacturing And Use For Therapeutic Protein Production And For Treatment
CA2940123CSystems And Methods For The Targeted Production Of A Therapeutic Protein Within A Target Cell
CA3097411A1Fusogenic Lipid Nanoparticles And Methods For The Manufacture And Use Thereof For The Target Cell-Specific Production Of A Therapeutic Protein And For The Treatment Of A Disease, Condition, Or Disorder Associated With A Target Cell
CA3047140A1Constructs For Expression Of Therapeutic Proteins In Target Cells
HK1218935ASystems And Methods For The Targeted Production Of A Therapeutic Protein Within A Target Cell
JPWO2019204666A5Fusogenic Lipid Nanoparticles And Methods Of Producing Fusogenic Lipid Nanoparticles For Target Cell-Specific Production Of Therapeutic Proteins And Treatment Of Target Cell-Related Diseases, Conditions, Or Disorders And How To Use
MX387916BExpression Construct For Transient Production Of A Casp9 Therapeutic Protein In A Senescent Human Target Cell.
MX387280BSystem For Targeted Production Of A Therapeutic Protein Within A Target Cell And Use Of The System.
IN202018041801ASystems And Methods For The Targeted Production Of A Therapeutic Protein Within A Target Cell
IN201917027258AFusogenic Lipid Nanoparticles And Methods For Manufacturing And Use For Therapeutic Protein Production And For Treatment
NZ713639ASystems And Methods For The Targeted Production Of A Therapeutic Protein Within A Target Cell
US20160051700A1Systems And Methods For The Targeted Production Of A Therapeutic Protein Within A Target Cell
US20160010110A1Systems And Methods For The Targeted Production Of A Therapeutic Protein Within A Target Cell
CN105518149ASystems And Methods For The Targeted Production Of Therapeutic Protein Within Target Cell
WO2020163408A3Fusogenic Lipid Nanoparticles For The Target Cell-Specific Production Of Rapamycin Inducible Therapeutic Proteins
WO2019204666A1Fusogenic Lipid Nanoparticles And Methods For The Manufacture And Use Thereof For The Target Cell-Specific Production Of A Therapeutic Protein And For The Treatment Of A Disease, Condition, Or Disorder Associated With A Target Cell
WO2018129563A1Fusogenic Lipid Nanoparticles And Methods For Manufacturing And Use For Therapeutic Protein Production And For Treatment
WO2014160661A3Systems And Methods For The Targeted Production Of A Therapeutic Protein Within A Target Cell
AU2021200496A1Systems And Methods For The Targeted Production Of A Therapeutic Protein Within A Target Cell
AU2014241622A1Systems And Methods For The Targeted Production Of A Therapeutic Protein Within A Target Cell
JP2020503390A5Fusogenic Lipid Nanoparticles And Methods For Their Production And Use For Target Cell-Specific Production Of Therapeutic Proteins And Treatment Of Diseases, Conditions, Or Disorders Associated With Target Cells
KR1020200074283ASystems And Methods For The Targeted Production Of A Therapeutic Protein Within A Target Cell
KR1020180118259ASystems And Methods For The Targeted Production Of A Therapeutic Protein Within A Target Cell
BR112015024605A2Systems And Methods For The Targeted Production Of Therapeutic Protein Within A Target Cell
IN9955DELNP2015ASystems And Methods For The Targeted Production Of A Therapeutic Protein Within A Target Cell
KR1020160002848ASystems And Methods For The Targeted Production Of A Therapeutic Protein Within A Target Cell

What are Oisin Biotechnologies’ key innovation segments?

What Technologies are Covered by Oisin Biotechnologies?

The chart below distributes patents filed by Oisin Biotechnologies in different countries on the basis of the technology protected in patents. It also represents the markets where Oisin Biotechnologies thinks it’s important to protect particular technology inventions.

R&D Focus: How has Oisin Biotechnologies’ search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Oisin Biotechnologies?

Related Articles

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.